Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

What's normal? Temporary shaking can occur after physical exertion, stress, or as a side effect of medication. Difficulty ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Meta-Description: Drugmaker AbbVie could be set up for a big year in 2025 after completing another successful clinical trial ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Aug. 5, 2024 — A research team examined the effect of Ecklonia cava polyphenols on the prevention of Parkinson's disease. It was found that the oral intake of the seaweed antioxidants restores ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Pereira FC et al. The Parkinson’s disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration. Nat ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...